Daniel Morgenstern, MD, PHD

The Hospital for Sick Children; Toronto, Canada – Staff Oncologist, Solid Tumor Program

Dr. Morgenstern is a Staff Oncologist at The Hospital for Sick Children, Toronto and Assistant Professor at the University of Toronto. He originally trained in the UK, including combined medical and PhD degrees from the University of Cambridge and clinical training at Great Ormond Street Hospital in London. He moved to Canada in 2016 and is currently Director of the New Agent and Innovative Therapy (NAIT) and Therapeutic mIBG Programs, and co-lead of the neuroblastoma service. Dr. Morgenstern’s clinical activities are focussed on neuroblastoma and solid tumour patients participating in early phase clinical trials. His research interests are similarly in early phase trials and, in particular, the use of immune checkpoint inhibitors in paediatric cancers and the development of precision medicine approaches for paediatric solid tumours.